Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature.
Saleh’s research thesis, ‘The role of integrin linked kinase in senescence and immunosuppressive tumor microenvironment in colon cancer’, identified that integrin-linked kinase (ILK) is associated with cancer prognosis and characterises the immunosuppressive tumor microenvironment. These findings suggest possible clinical avenues of targeting ILK combined with current colorectal cancer therapy, specifically immunotherapy.
“I could not have reached this stage without the support and guidance of my supervisors and really appreciate everything they have provided me during my milestones, meetings and lab work,” said Saleh.
Saleh started his PhD at Cartherics in 2019 under the guidance of supervisor, Professor Bryan Williams and co-supervisors, Dr Afsar Ahmed and Professor Richard Boyd.
Saleh has now commenced his new role as a Lecturer at Najran University in Saudi Arabia, where he teaches histopathology and cytopathology. He is also working in the development and quality of the clinical laboratory sciences at the University’s College of Applied Medical Sciences.
Cartherics has developed innovative Masters and PhD research programs of study that include world-class research training, as well as opportunities to develop diverse commercialisation and clinical translation skills that will benefit their future careers. The Cartherics Higher Degree Programs centre on medical research specifically combining stem cells and immunotherapy to cure cancer. For further details please visit: https://cartherics.com/careers/opportunities/